Ras p21 immunohistochemical detection in human endometrial carcinomas

Gynecologic and Obstetric Investigation

Volumn 44, Issue 2, 1997, Pages 132-135

  Semczuk, Andrzej ^a   Miturski, Roman ^a   Baranowski, Wtodzimierz ^a   Jakowicki, Jerzy A ^a  

^a Lublin School of Medicine   (Poland)

Author keywords

H score; Human endometrial cancer; Immunohistochemistry; Ras p21 protein

Indexed keywords

PROTEIN P21;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CYTOPLASM; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOMETRIUM; ONCOGENE RAS; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOCARCINOMA, CLEAR CELL; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, ADENOSQUAMOUS; COHORT STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEIN P21(RAS); RABBITS;

EID: 0030931098     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291504     Document Type: Article

References (28)

1. Parazzini F, La Vecchia C, Bocciolone L, Fran-ceschi S: The epidemiology of endometrial cancer. Gynecol Oncol 1991;41:1-16.
2. Kauppila A, Gronroos M, Nieminen U: Clinical outcome in endometrial cancer. Obstet Gynecol 1982;60:473-480.
3. Christopherson WM; The significance of the pathologic findings in endometrial cancer. Clin Obstet Gynecol 1986;13:673-693.
4. Grigsby PW, Perez CA, Kuske RR. Kao MS, Galakatos AE: Results of therapy, analysis of failures, and prognostic factors for clinical and pathological stage III adenocarcinoma of the endometrium. Gynecol Oncol 1987;27:44-57.
5. Harouny VR, Sutton GP, Clare SA, Geisler HE, Stehman FB, Ehrlich CE: The importance of peritoneal cytology in endometrial carcinoma. Obstet Gynecol 1988;72:394-398.
6. Britton LC, Wilson TO, Gaffey TA, Lieber MM, Wicand HS, Podratz KC: Flow cytometric DNA analysis of stage I endometrial carcinoma. Gynecol Oncol 1989;34:317-322.
7. Barbacid M: ras genes. Annu Rev Biochem 1987;56:779-827.
8. Boguski MS, McCormick F: Proteins regulating ras and its relatives. Nature 1993;366:643-654.
9. Bos JL: p21rax: An oncoprotein functioning in growth factor-induced signal transduction. Eur J Cancer 1995;31A: 1051-1054.
10. Fotiou SK, Tserkezoglou AJ, Mahera H, Kon-standinidou AE, Agnantis NJ, Pandis N, Bardi G: Chromosome aberrations and expression of ras and myc oncogenes in leiomyomas and a leiomyosarcoma of the uterus. Eur J Gynaecol Oncol 1992;13:340-345.
11. Yaginuma Y, Yamashita K, Kuzumaki N, Fu-jita M, Shimizu T: ras oncogene product p21 expression and prognosis of human ovarian tumors. Gynecol Oncol 1992;46:45-50.
12. Gaducci A, Ciancia EM, Campani D, Malagni-no G, De Luca F, Facchini V, Pingitore R, Fioretti P: Immunohistochemical detection of pi85, p21 product, and proliferating cell nuclear antigen (PCNA) in formalin-fixed, paraffin-embedded tissues from ovarian carcinomas. Eur J Gynaecol Oncol 1994;15:359-368.
13. Sagae S, Kuzumaki N, Hisada T, Mugikura Y. Kudo R, Hashimoto M: ras oncogene expression and prognosis of invasive squamous cell carcinomas of the uterine cervix. Cancer 1989; 63:1577-1582.
14. Sagae S, Kudo R, Kuzumaki N, Hisada T, Mugikura Y, Nihei T, Takeda T. Hashimoto M: ras oncogene expression and progression in intraepithelial neoplasia of the uterine cervix. Cancer 1990;66:295-301.
15. Hayashi Y, Hachisuga T, Iwasaka T, Fukuda K, Okuma Y, Yokoyama M, Sugimori H: Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement. Gynecol Oncol 1991;40:147-151.
16. Scambia G, Catozzi L, Benedctti-Panici P, Fer-randina G, Coronetta F, Barozzi R, Baiocchi G, Uccelli L, Pifanelli A, Mancuso S: Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues. Correlation with histopathological features and receptors for estrogen, progesterone, and epidermal growth factor. Am J Obstet Gynecol 1993;168:71-78.
17. Long CA, O’Brien TJ, Sanders MM, Bard DS, Quirk JG Jr: ras oncogene is expressed in adenocarcinoma of the endometrium. Am J Obstet Gynecol 1988;159:1512-1516.
18. Yaginuma Y, Fujita M, Saitoh S, Hayakawa K. Kuzumaki N, Ishikawa M: Immunohistochemical analysis of ras oncogene product p21 in human endometrial carcinoma. Acta Histo-chem 1993;95:23-29.
19. Scambia G, Catozzi L, Benedetti-Panici P, Fer-randina G, Battaglia F, Giovannini G, Distefa-no M, Pellizzola D, Piffanelli A, Mancuso S: Expression of ras p21 oncoprotein in normal and neoplastic human endometrium. Gynecol Oncol 1993;50:339-346.
20. Agnantis NJ, Spandidos DA, Mahera H, Paris-si P, Kakkanas A, Pintzas A, Papacharalam-pous NX: Immunohistochemical study of ras oncogene expression in endometrial and cervical human lesions. Eur J Gynaecol Oncol 1988; 5:360-366.
21. Miturski R, Semczuk A, Jakowicki JA: ras oncogene product p21 expression in adenocarcinoma of human endometrium. Cell Mol Biol Lett 1996;1:145-149.
22. FIGO stages: 1988 revision. Gynecol Oncol 1989;35:125-127.
23. Scully RE, Bonfiglio TA, Kurman RJ, Silver-berger SG, Wilkinson EJ: Histological Typing of Female Genital Tract Tumours. Berlin, Springer, 1994.
24. Nyholm HCJ, Nielsen AL, Lyndrup J, Norup P, Thorpe SM: Biochemical and immunohistochemical estrogen and progesterone receptors in adenomatous hyperplasia and endometrial carcinoma: Correlation with stage and other clinicopathologic features. Am J Obstet Gynecol 1992;167:1334-1342.
25. Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS, Podratz KC: HER-2/neu expression: A major prognostic factor in endometrial cancer. Gynecol Oncol 1992;47:179-185.
26. Ito K, Watanabe K, Nasim S, Sasano H, Sato S, Yajima A, Silverberg SG, Garrett CT: Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res 1994;54:4667-4670.
27. Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC Jr, Marks JR: Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 1992:52:1622-1627.
28. Semczuk A, Miturski R, Tomaszewski J, Pu-towski LT, Jakowicki JA: Assessment of p53 protein expression in human endometrial carcinomas. Ginekol Pol 1996;67(suppl 6): 119-123.